Roche said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its ...

In the current study, researchers at the U.S. Department of Agriculture-Arkansas Children's Nutrition Center found that foetal exposure to gestational obesity leads to a self-reinforcing vicious ...

BioAge Labs Inc., a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, is seeking ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

JAMA published a review on medications for obesity. BMI is still "a valuable method" for defining obesity despite its flaws, argued authors of an Annals of Internal Medicine opinion piece.

Eli Lilly’s tirzepatide, the in-demand drug sold as Zepbound for weight loss, has for the first time been shown in late-stage testing ... placebo in people with obesity. Some participants ...

With the Congress Programme Committee also recognizing the contributions of obesity medicine and management in the cardiovascular space, and that this has very much become a public health issue ...

The documents were needed to verify testing and manufacturing practices at Granules, a company in Telangana, India, that supplies generic medications to the U.S., officials say. More pharmaceutical ...

FRANKFURT (Reuters) - Shares in Roche fell on Thursday after an early-stage obesity pill candidate that carries high market hopes was linked to a high rate of temporary side effects in its initial ...

FRANKFURT (Reuters) - Roche said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its shares in July were based on just six patients ...